Get the Stockscreener App
4.95
4.65%
0.22
22nd Century Group, Inc. stock is traded at $4.95, with a volume of 101.99K.
It is up +4.65% in the last 24 hours and down -62.20% over the past month.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
See More
Previous Close:
$4.73
Open:
$4.74
24h Volume:
101.99K
Relative Volume:
1.52
Market Cap:
$2.74M
Revenue:
$29.78M
Net Income/Loss:
$-39.94M
P/E Ratio:
-0.934
EPS:
-5.3
Net Cash Flow:
$-16.12M
1W Performance:
-25.32%
1M Performance:
-62.20%
6M Performance:
-93.89%
1Y Performance:
-98.83%
1-Day Range:
$4.61
$5.28
1-Week Range:
$3.90
$6.075
52-Week Range:
$3.90
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
Compare XXII with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
4.95 | 2.74M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-22 | Initiated | Alliance Global Partners | Buy |
| Jun-15-22 | Initiated | Craig Hallum | Buy |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Jul-23-21 | Initiated | Cowen | Outperform |
| Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
| Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
StockNews.com Begins Coverage on 22nd Century Group (NASDAQ:XXII) - MarketBeat
22nd Century Group announces reverse stock split - Investing.com
22nd Century Group announces reverse stock split By Investing.com - Investing.com UK
22nd Century : Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors - Marketscreener.com
22Nd Century Group Expands VLN Tobacco Growing Program to Support Anticipated Demand of the Company’S Reduced Nicotine Content Cigarettes - Marketscreener.com
22nd Century Group, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
XXII Stock Plummets to 52-Week Low of $0.04 Amid Market Turbulence By Investing.com - Investing.com South Africa
22nd Century : Reduces Debt by Additional $1.5 Million via Payment from GVB Form 8 K - Marketscreener.com
22nd Century Group, Inc. announced that it expects to receive $1.6815 million in funding - Marketscreener.com
22nd Century Group (NASDAQ:XXII) Stock Quotes, Forecast and News Summary - Benzinga
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet - Benzinga
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings - Benzinga
22nd Century Group to execute 1-for-135 reverse stock split - MSN
22nd Century Announces 1-for-135 Reverse Stock Split - Yahoo Finance
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes - The Kingston Whig-Standard
Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail
22nd Century Group approves reverse stock split By Investing.com - Investing.com Nigeria
22nd Century Group approves reverse stock split - Investing.com India
12 Cannabis Stocks to Buy Now in 2024 - MarketBeat
22nd Century Net Loss Widens - Tobacco Reporter
22nd Century: Q3 Earnings Snapshot - CT Insider
XXII stock plunges to 52-week low of $0.09 amid market challenges - Investing.com
22nd Century Group Inc (XXII) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
22nd Century Group Faces Ongoing Financial Challenges - TipRanks
22nd Century Group Q3 Revenue Falls to $5.9M, Eyes EBITDA Breakeven Despite Losses | XXII Stock News - StockTitan
22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024 - Newsfile
22nd Century Group (XXII) Sets Q3 2024 Earnings Call for November 12 | XXII Stock News - StockTitan
22nd Century Raises $1.68 Million in Regulation A Offering, Amends Senior Secured Credit Facility - MSN
Cookies Retail sues Cookies Creative over settlement breach - Green Market Report
22nd Century Group, Inc. announced that it expects to receive $3.039363 million in funding - Marketscreener.com
What's Going On With 22nd Century Stock? - MSN
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving PremarketStride (NYSE:LRN) - Benzinga
22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles - Newsfile
22nd Century Group (NASDAQ:XXII) Coverage Initiated at StockNews.com - Defense World
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga
XXII stock plunges to 52-week low of $0.15 amid market challenges By Investing.com - Investing.com South Africa
XXII stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
22nd Century Group modifies credit terms with JGB - Investing.com
22nd Century Group modifies credit terms with JGB By Investing.com - Investing.com Canada
Recent Securities Cases Highlight Risks In AI Disclosures - Law360
22nd Century Group meets Nasdaq equity rule - Investing.com
22nd Century Group meets Nasdaq equity rule By Investing.com - Investing.com Australia
22nd Century Surpasses Nasdaq Equity Requirements - TipRanks
22nd Century Regains Compliance with Nasdaq Stockholders' Equity Requirement - Yahoo Finance
22nd Century Group meets NASDAQ equity requirement By Investing.com - Investing.com Australia
22nd Century Group meets NASDAQ equity requirement - Investing.com India
22nd Century claims compliance reached with Nasdaq requirement - Winston-Salem Journal
XXII stock plunges to 52-week low, touches $0.23 - Investing.com
22nd Century Group, Inc. Stock (XXII) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):